X

JAMA Oncology

JAMA Oncology
Comparison of Systemic Treatments for Metastatic Castration-Sensitive Prostate Cancer

This study seeks to answer the question surrounding the most effective systemic treatments for metastatic castration-sensitive prostate cancer.

JAMA Oncology
01/14/2021
Evaluation of Safety of Stereotactic Body Radiotherapy for the Treatment of Patients With Multiple Metastases

Can ablative radiation schedules designed for single tumors be used when treating patients with 3 to 4 metastases or 2 metastases in close proximity to each other?

JAMA Oncology
04/22/2021
Frequency of and Factors Associated With Nonmedical Opioid Use Behavior Among Patients With Cancer Receiving Opioids for Cancer Pain

This study examines the predictors for and frequency of the presence of nonmedical opioid use behavior in patients with cancer.

JAMA Oncology
Comparison of Systemic Treatments for Metastatic Castration-Sensitive Prostate Cancer

This study seeks to answer the question surrounding the most effective systemic treatments for metastatic castration-sensitive prostate cancer.

JAMA Oncology
Association of Race/Ethnicity and the 21-Gene Recurrence Score With Breast Cancer–Specific Mortality Among US Women

This retrospective cohort study finds that compared with non-Hispanic White women, Black women are more likely to have a high-risk recurrence score and had higher breast cancer–specific mortality..

JAMA Oncology
US State Government Crisis Standards of Care Guidelines: Implications for Patients With Cancer

In this cross-sectional analysis of CSC guidelines, 55% deprioritized some patients with cancer, and 26% categorically excluded some patients with cancer during...

JAMA Oncology
Effectiveness of Integrated Palliative and Oncology Care for Patients With Acute Myeloid Leukemia

This randomized clinical trial seeks to answer the question of the effect of IPC on patient-reported and end-of-life outcomes for patients with acute myeloid leukemia.

JAMA Oncology
Efficacy of Pazopanib With or Without Gemcitabine in Patients With Anthracycline- and/or Ifosfamide-Refractory Soft Tissue Sarcoma

This study further examined the tolerability and efficacy of pazopanib and gemcitabine compared with pazopanib alone in pretreated soft tissue sarcoma. 

JAMA Oncology
Safety and Survival Rates Associated With Ablative Stereotactic Radiotherapy for Patients With Oligometastatic Cancer

This study aims to answer the question is stereotactic ablative radiotherapy safe and clinically beneficial in the management of oligometastatic cancer.

JAMA Oncology
11/25/2020
Metastatic Disease as a Distinct Discipline in Radiation Oncology

 

The treatment paradigm for patients with metastatic cancer has shifted in the era of oligometastatic disease, novel systemic therapy, and local ablative therapy options such as SABR.

JAMA Oncology
Subscribe to JAMA Oncology

source list reference

#7d60d9
#2694a4
#32a887
#85eb24
#352625
#4d4537
#d2093c
#8e3f1c
#76b6c3
#bfcfc8
#c61417
#67e25b
#efef71
#03cffc
#42fc9a
#cc529a
#c59445
#c8cc0c
#bf6be3
#e8085a
#97d1a0
#74e391
#eb6342
#b61f77
#a153ac
#e7f6e3
#6fc969
#9a8c2c
#a9c507
#2b9ab3
#e61923
#990677
#4a7bab
#89f67c
#49a21d
#2c990a
#d7da81
#575662
#a60538
#49cde9
#c20fce
#d95d39